Ilya is a pharmaceutical company that researches and develops biological drugs for treating wounds in skin and mucosa... Read more
Ilya Pharma  Co-Founder & CEO: Evelina Vagesjo

Co-Founder & CEO

Evelina Vagesjo

CEO Approval Rating

81/100

Est. Annual Revenue
<$1M
Agree?
Est. Employees
1-25
Agree?
Funding
$9.9M
Acquisitions
1
Investments
1

News

Apr 01, 2025
Cision
Press Release: Ilya Pharma : Ilya Pharma publishes data on potent bacterial killing effect by ILP100 on totally resistant bacterial pathogens from Ukrainian war victims
Feb 07, 2025
Cision
Press Release: Ilya Pharma : Ilya Pharma CEO selected for Eisenhower Fellowship named after American President Dwight D. Eisenhower to promote global peace and development
Sep 11, 2024
Cision
Press Release: Ilya Pharma : Ilya Pharma receives Rare Pediatric Disease Designation from the U.S. FDA for emilimogene sigulactibac for the treatment of skin wounds in SAVI patients
Sep 13, 2022
FirstWord Pharma
Ilya Pharma : Ilya Pharma presents first in class wound healing treatment at US Defense Department's MHSRS 2022 Conference in Florida
May 23, 2022
Cision
Press Release: Ilya Pharma : Ilya Pharma extends global patent coverage for ILP100 for the treatment of diseases of skin and mucosa in humans and animals
May 04, 2022
FirstWord Pharma
Ilya Pharma : Ilya Pharma announces FDA clearance of IND for first-in-class ILP100-Topical immunotherapy treatment of surgical wounds in patients with prediabetes, diabetes and obesity
Apr 21, 2022
Contract Pharma
Ilya Pharma : Ilya Pharma Acquires Nordic Bioanalysis
Apr 19, 2022
Cision
Press Release: Ilya Pharma : Ilya Pharma makes strategic investment in bioanalytical company Nordic Bioanalysis to strengthen supply chain
Mar 16, 2022
FirstWord Pharma
Ilya Pharma : Ilya Pharma closes Euros 8.5 million to advance its clinical programs
Jan 12, 2022
Cision
Press Release: Ilya Pharma : Ilya Pharma announces plan for clinical development of ILP100-Oral targeting cancer treatment mediated enterocolitis

Trending Companies